glp-1 anesthesia guidelines 2025 Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists aGLP-1 receptor agonists & anesthesia:

9.Mahase E (2024) GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment

As Section 107A(a) provides that certain acts shall not be considered patent infringement, specifically allowing for the making, constructing, using, selling, or importing of a patented invention solely for uses reasonably related to the development and submission of information required under any law, whether in India or in another country, that governs the manufacture, construction, use, sale, or import of any product

Dose titration schedule Clinicians typically start patients at a lower dose (0.8 mg) and gradually increase it over several weeks or months

It has been hypothesized that liraglutide and semaglutide act through different neurological pathways, providing the rationale for their different efficacy in inducing weight loss [54]

The most common side effects patients report are nausea (55%), diarrhea (12%), and stomach pain (9%)